Skip to main content

Table 2 Time on mood stabilizing treatment since baseline and retention rates during the study

From: Comparably high retention and low relapse rates in different subpopulations of bipolar patients in a German non-interventional study

Cohort

N

Mean [days]

95% CI [days]

SD [days]

1st Quartile [days]

Median [days]

3rd Quartile [days]

Retention-Rate (%)

95% CI (%)

OM

186

433.5

408.4 - 458.5

173.0

335

520

548

88.1

82.1 - 92.1

LM

152

481.3

458.7 - 504.0

141.2

486

534

554

93.6

88.0 - 96.6

AM

216

440.4

416.8 - 464.0

175.8

363

527

558

83.8

77.8 - 88.3

OLC

47

475.1

428.4 - 521.8

159.1

454

538

570

87.1

73.4 - 94.0

OAC

68

417.5

371.1 - 463.9

191.8

262

514

552

86.8

75.2 - 93.2

OC

48

462.2

413.9 - 510.5

166.3

403

529

568

84.2

69.7; 92.2

OMS

44

377.5

318.8 - 436.2

193.1

230

484

531

85.9

71.3; 93.4

Total sample

761

444.7

432.5 - 456.9

171.2

374

525

554

87.7

85.1 - 90.0

  1. Abbreviations: OM Olanzapine monotherapy, LM Lithium monotherapy, AM Anticonvulsive monotherapy, OLC Olanzapine/lithium combination therapy, OAC Olanzapine/anticonvulsive combination therapy, OC Other combinations of mood-stabilizers, OMS Other mood stabilizing therapy, SD standard deviation, CI confidence interval.
  2. Start date was start of documentation. The end date was date of either the first discontinuation or switch of mood stabilizing medication, death, or the last documented visit.